Pancreatic Cancer Research

ResearcherZhejiang Cancer HospitalNo recent work listed

Tianyu Tang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4825-2189; OpenAlex author ID A5031042929. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2020: 4 papers · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper

Papers 9

  1. Transcriptional control of pancreatic cancer immunosuppression by metabolic enzyme CD73 in a tumor-autonomous and -autocrine manner. Co-author DOI 10.1038/s41467-023-38578-3↗
  2. Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis. Co-author DOI 10.1136/jitc-2021-004129↗
  3. Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine. Co-author DOI 10.1186/s40779-022-00416-w↗
  4. NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1. Co-author DOI 10.1038/s41467-021-24769-3↗
  5. Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development. Co-author DOI 10.1186/s12943-021-01310-0↗
  6. Calreticulin couples with immune checkpoints in pancreatic cancer. First author DOI 10.1002/ctm2.10↗
  7. Development of a Novel Multiparametric MRI Radiomic Nomogram for Preoperative Evaluation of Early Recurrence in Resectable Pancreatic Cancer. Co-author DOI 10.1002/jmri.27024↗
  8. Role of imaging biomarkers for prognostic prediction in patients with pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.crad.2019.12.023↗
  9. The efficacy and toxicity of chemotherapy in the elderly with advanced pancreatic cancer. Co-author DOI 10.1016/j.pan.2019.11.012↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tingbo Liang · 8 shared papers, 2020–2023 · strength 1.21
  2. Xing Huang · 6 shared papers, 2020–2023 · strength 1.03
  3. Gang Zhang · 5 shared papers, 2021–2023 · strength 0.89
  4. Xueli Bai · 3 shared papers, 2020–2021 · strength 0.30
  5. Xiaozhen Zhang · 2 shared papers, 2020–2021 · strength 0.21
  6. Mengyi Lao · 2 shared papers, 2020–2021 · strength 0.21
  7. Xiang Li · 2 shared papers, 2020 · strength 0.18
  8. Qi Zhang · 2 shared papers, 2020 · strength 0.18
  9. Risheng Que · 2 shared papers, 2020 · strength 0.18
  10. Wei Chen · 2 shared papers, 2020 · strength 0.18
  11. Zhengtao Hong · 1 shared paper, 2022 · strength 0.16
  12. Xiao Zhi · 1 shared paper, 2022 · strength 0.16
  13. Junming Huang · 1 shared paper, 2022 · strength 0.16
  14. Xueli Bai · 1 shared paper, 2020 · strength 0.15
  15. Xiangyang Gong · 1 shared paper, 2020 · strength 0.13
  16. Sijia Cui · 1 shared paper, 2020 · strength 0.13
  17. Jian Xu · 1 shared paper, 2021 · strength 0.12
  18. Dipesh Kumar Yadav · 1 shared paper, 2021 · strength 0.12
  19. Enliang Li · 1 shared paper, 2021 · strength 0.12
  20. Tao Ma · 1 shared paper, 2020 · strength 0.09
  21. Qihan Fu · 1 shared paper, 2020 · strength 0.09
  22. Yinan Shen · 1 shared paper, 2020 · strength 0.09
  23. Ri‐Sheng Yu · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.